0001370053-22-000036.txt : 20220624 0001370053-22-000036.hdr.sgml : 20220624 20220624160543 ACCESSION NUMBER: 0001370053-22-000036 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20220623 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20220624 DATE AS OF CHANGE: 20220624 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ANAPTYSBIO, INC CENTRAL INDEX KEY: 0001370053 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 203828755 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37985 FILM NUMBER: 221040057 BUSINESS ADDRESS: STREET 1: 10770 WATERIDGE CIRCLE, SUITE 210 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-362-6295 MAIL ADDRESS: STREET 1: 10770 WATERIDGE CIRCLE, SUITE 210 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: ANAPTYSBIO INC DATE OF NAME CHANGE: 20080828 FORMER COMPANY: FORMER CONFORMED NAME: ANAPTYS BIOSCIENCES INC DATE OF NAME CHANGE: 20060724 8-K 1 anab-20220623.htm 8-K anab-20220623
0001370053false00013700532022-06-232022-06-23

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT PURSUANT TO
SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report: June 23, 2022
(Date of earliest event reported)

ANAPTYSBIO, INC.
(Exact Name of Registrant as Specified in Charter)

Delaware001-3798520-3828755
(State or Other Jurisdiction of Incorporation)(Commission File Number)(IRS Employer Identification No.)
            
10770 Wateridge Circle, Suite 210,
San Diego, CA 92121
(Address of Principal Executive Offices, and Zip Code)

(858) 362-6295
(Registrant’s Telephone Number, Including Area Code)

Not Applicable
(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.001 per share
ANAB
The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 5.07.     Submission of Matters to a Vote of Security Holders.

On June 23, 2022, AnaptysBio, Inc. (the “Company”) held its 2022 Annual Meeting of Stockholders and the following proposals were adopted:

1.Election of three Class II directors, Laura J. Hamill, James Topper, M.D., Ph.D., and J. Anthony Ware, M.D., each to serve a three-year term, which will expire at the 2025 Annual Meeting of Stockholders or until such time as his or her respective successor have been duly elected and qualified or until such director’s earlier resignation or removal:

NomineesShares ForShares Withheld / AbstainingBroker Non-Votes
Laura J. Hamill18,530,9643,884,1042,986,393
James Topper, M.D., Ph.D.18,338,9604,076,1082,986,393
J. Anthony Ware, M.D.18,397,9044,017,1642,986,393

2.Ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022:

Shares ForShares AgainstShares Withheld/AbstainingBroker Non-Votes
25,369,48330,5401,438

3.Non-binding, advisory approval of compensation paid to the Company’s named executive officers:

Shares ForShares AgainstShares Withheld/AbstainingBroker Non-Votes
21,241,1281,166,6957,2452,986,393




SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

                   
AnaptysBio, Inc.
Date: June 24, 2022By:/s/ Eric Loumeau
Name: Eric Loumeau
Title: Chief Operating Officer and General Counsel


EX-101.SCH 2 anab-20220623.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 3 anab-20220623_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 4 anab-20220623_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Address, Postal Zip Code Entity Address, Postal Zip Code Document [Domain] Document [Domain] Document Period End Date Document Period End Date Entity Central Index Key Entity Central Index Key Address Type [Domain] Address Type [Domain] Entity Addresses, Address Type [Axis] Entity Addresses, Address Type [Axis] Document Information [Table] Document Information [Table] Entity Emerging Growth Company Entity Emerging Growth Company Security Exchange Name Security Exchange Name Title of 12(b) Security Title of 12(b) Security Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Registrant Name Entity Registrant Name Written Communications Written Communications Local Phone Number Local Phone Number Entity Addresses [Table] Entity Addresses [Table] Soliciting Material Soliciting Material Entity Address, State or Province Entity Address, State or Province City Area Code City Area Code Document Type Document Type Document Information [Line Items] Document Information [Line Items] Cover [Abstract] Cover [Abstract] Entity Address, City or Town Entity Address, City or Town Pre-commencement Tender Offer Pre-commencement Tender Offer Entity File Number Entity File Number Document Information, Document [Axis] Document Information, Document [Axis] Amendment Flag Amendment Flag Entity Addresses [Line Items] Entity Addresses [Line Items] Trading Symbol Trading Symbol Entity Tax Identification Number Entity Tax Identification Number EX-101.PRE 5 anab-20220623_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 6 R1.htm IDEA: XBRL DOCUMENT v3.22.2
Cover Page
Jun. 23, 2022
Cover [Abstract]  
Document Type 8-K
Document Period End Date Jun. 23, 2022
Entity Registrant Name ANAPTYSBIO, INC
Entity Incorporation, State or Country Code DE
Entity File Number 001-37985
Entity Tax Identification Number 20-3828755
Entity Address, Address Line One 10770 Wateridge Circle
Entity Address, Address Line Two Suite 210,
Entity Address, City or Town San Diego
Entity Address, State or Province CA
Entity Address, Postal Zip Code 92121
City Area Code 858
Local Phone Number 362-6295
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.001 per share
Trading Symbol ANAB
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Entity Central Index Key 0001370053
Amendment Flag false
Document Information [Line Items]  
Document Type 8-K
Entity Addresses [Line Items]  
Entity Address, Address Line One 10770 Wateridge Circle
Entity Address, Address Line Two Suite 210,
Entity Address, City or Town San Diego
Entity Address, State or Province CA
Entity Address, Postal Zip Code 92121
XML 7 anab-20220623_htm.xml IDEA: XBRL DOCUMENT 0001370053 2022-06-23 2022-06-23 0001370053 false 8-K 2022-06-23 ANAPTYSBIO, INC DE 001-37985 20-3828755 10770 Wateridge Circle Suite 210, San Diego CA 92121 858 362-6295 false false false false Common Stock, par value $0.001 per share ANAB NASDAQ false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2 html 1 23 1 false 0 0 false 0 false false R1.htm 0001001 - Document - Cover Page Sheet http://www.anaptysbio.com/role/CoverPage Cover Page Cover 1 false false All Reports Book All Reports anab-20220623.htm anab-20220623.xsd anab-20220623_def.xml anab-20220623_lab.xml anab-20220623_pre.xml http://xbrl.sec.gov/dei/2021q4 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "anab-20220623.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "definitionLink": { "local": [ "anab-20220623_def.xml" ] }, "inline": { "local": [ "anab-20220623.htm" ] }, "labelLink": { "local": [ "anab-20220623_lab.xml" ] }, "presentationLink": { "local": [ "anab-20220623_pre.xml" ] }, "schema": { "local": [ "anab-20220623.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" ] } }, "elementCount": 32, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021q4": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 0, "memberStandard": 0, "nsprefix": "anab", "nsuri": "http://www.anaptysbio.com/20220623", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "anab-20220623.htm", "contextRef": "i476584aaf17f4178b0da998a078e3bfe_D20220623-20220623", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover Page", "role": "http://www.anaptysbio.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "anab-20220623.htm", "contextRef": "i476584aaf17f4178b0da998a078e3bfe_D20220623-20220623", "decimals": null, "lang": "en-US", "name": "dei:DocumentPeriodEndDate", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AddressTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An entity may have several addresses for different purposes and this domain represents all such types.", "label": "Address Type [Domain]", "terseLabel": "Address Type [Domain]" } } }, "localname": "AddressTypeDomain", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_DocumentDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards.", "label": "Document [Domain]", "terseLabel": "Document [Domain]" } } }, "localname": "DocumentDomain", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "dei_DocumentInformationDocumentAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.", "label": "Document Information, Document [Axis]", "terseLabel": "Document Information, Document [Axis]" } } }, "localname": "DocumentInformationDocumentAxis", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]", "terseLabel": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]", "terseLabel": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityAddressesAddressTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.", "label": "Entity Addresses, Address Type [Axis]", "terseLabel": "Entity Addresses, Address Type [Axis]" } } }, "localname": "EntityAddressesAddressTypeAxis", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_EntityAddressesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Addresses [Line Items]", "terseLabel": "Entity Addresses [Line Items]" } } }, "localname": "EntityAddressesLineItems", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_EntityAddressesTable": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Container of address information for the entity", "label": "Entity Addresses [Table]", "terseLabel": "Entity Addresses [Table]" } } }, "localname": "EntityAddressesTable", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 14 0001370053-22-000036-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001370053-22-000036-xbrl.zip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end